Study: HPV Gardasil Vaccine Linked to Decline in Fertility Rates in U.S. Women Aged 25–29

A major study has just been published in the Journal of Toxicology and Environmental Health looking at declining fertility rates among eight million U.S. women aged 25 to 29 during a 7-year period. The title of study, published by Gayle DeLong, Ph.D., from the Department of Economics and Finance, Baruch College/City University of New York, is "A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection." From the abstract: "This study analyzed information gathered in National Health and Nutrition Examination Survey, which represented 8 million 25-to-29-year-old women residing in the United States between 2007 and 2014. Approximately 60% of women who did not receive the HPV vaccine had been pregnant at least once, whereas only 35% of women who were exposed to the vaccine had conceived. Using logistic regression to analyze the data, the probability of having been pregnant was estimated for females who received an HPV vaccine compared with females who did not receive the shot. Results suggest that females who received the HPV shot were less likely to have ever been pregnant than women in the same age group who did not receive the shot. If 100% of females in this study had received the HPV vaccine, data suggest the number of women having ever conceived would have fallen by 2 million."

Gardasil: The Decision We Will Always Regret – 7 Years Later – Finding A Long and Never-ending Path to Healing

In February of 2015, Kim Robinson reached out to us to see if we would publish her daughter's story about Gardasil vaccine injuries. It was originally published on SaneVax.org. We had published many stories of Gardasil vaccine injuries before that time, and we have published many since that time. Some of the stories we have published have been very heart-breaking, with some, tragically, ending in death. Yet for some reason, that probably nobody can completely explain, Kim's daughter, Katie, became the "poster child" for the many thousands of Gardasil vaccine injury stories. Her story, published just on the Health Impact News network, has been shared on Facebook over 5 million times over the years, besides all the other social media outlets and other websites where her story appears. So it is with great joy that Health Impact News now publishes Kim Robinson's 7-year follow-up report on her daughter, Katie, just as she graduates from High School this year, showing that with lots of love and hard work, a path to healing is possible. Kim writes: "When my husband and I look back at our lives before Gardasil, it seems dreamlike. We were living our American Dream. We were married, had good jobs, bought a home to raise our two healthy kids in and were leading a vibrant family life. That was until September 2, 2010, when we took our daughter to the Pediatrician and consented to the administration of a vaccine we knew nothing about. Everything changed that day and the damage from one jab of Gardasil almost cost us every part of our American Dream including the life of our precious daughter. The funny thing is that I am a paralegal. I research EVERYTHING before making a purchase or before making important choices especially decisions that affect my children. In hindsight, we can’t imagine why, but we never thought about researching a vaccine. All we knew about vaccines was what we now recognize as well derived marketing slogans such as 'vaccines are safe and effective' or 'vaccines save lives.' Every day, we wish we would have heard just one warning so that we could have saved our precious daughter from years of suffering and quite possibly a lifetime of health issues."

Gardasil HPV Vaccine Acceptance into China Creates Instant Billionaires

Last month (May, 2018) we published a report from the vaccine marketing trade publication, Fierce Pharma, that Merck's sales this year were beating financial forecasts, primarily due to its entrance into the China market for its top-selling Gardasil HPV vaccine. Fierce Pharma reported at that time that the Gardasil vaccine was fast-tracked for approval into the China market: "Late last month, the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review." Now, Fierce Pharma is reporting that Gardasil's acceptance into the China market has produced instant billionaires.

Japan Leading the World in Exposing Fraud with Gardasil HPV Vaccine Injuries and Deaths

In Japan, young women and girls suffering from severe chronic generalized pain following vaccination with Merck’s Gardasil® or GSK’s Cervarix®, have organized and are speaking out. The issues are being debated at public hearings, at which scientific presentations have been made by independent medical experts who validated the women’s suffering with documented evidence of the severe nature of the pain related to the HPV vaccine. Such public debates do not take place where vaccine stakeholders are in full control of vaccine safety information. (Like in the U.S., for example.) Following a public hearing (February 2014), at which scientific evidence was presented by independent scientists, the Japanese government, not only rescinded its recommendation that girls receive the HPV vaccine, but established guidelines and special clinics for evaluating and treating illnesses caused by the vaccine. It is a scenario that Merck, GSK, and vaccine stakeholders globally are extremely anxious to suppress.

As Merck’s Gardasil U.S. Sales Decline Profits Continue to Increase as Vaccine is Launched in China

The pharmaceutical marketing trade publication, Fierce Pharma, announced this month (May 2018) that Merck has beat Wall Street expectations for their Gardasil vaccine sales during the first quarter of 2018, achieving 24% growth with $660 million for the HPV vaccine. The report notes that sales in the U.S. are declining, attributing the decline in sales to the CDC decision to reduce their recommendation of the Gardasil vaccine to be only two doses, instead of three. Nothing is mentioned about declining public opinion regarding Gardasil, nor the numerous lawsuits against the company outside the U.S. The increase in sales for Gardasil is attributed to their entrance into the China market. The original vaccine won Chinese approval last year, while late last month the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review.

U.S. Taxpayer Funds Used To Develop and Market Merck’s Gardasil Vaccine Global Empire

It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer Paul Offit, for example, who is one of the nation’s leading promoters of mandatory use of government recommended vaccines, holds a $1.5 million research chair at Children’s Hospital in Philadelphia, funded in part by Merck. Julie Gerberding left her post as Director of the Centers for Disease Control and Prevention (CDC), where she oversaw the creation of national vaccine policies, to head Merck vaccines. Former Texas governor Rick Perry recommended state-wide inoculation of all 11- and 12-year-old girls with Merck’s Gardasil vaccine after his chief of staff left to work at Merck. Just as disturbing are the millions of dollars that officials at the National Institutes of Health (NIH) dole out to academic institutions and vaccine manufacturers to improve vaccine technology, find new, lucrative markets and boost vaccine marketability—functions that guarantee the profitability of corporations, but do not always ensure the well being of taxpayers, the public and patients. Today, taxpayer-supported research to develop new drugs and vaccines is voraciously patented by universities and drug companies for outsized Wall Street profits when the research rightfully belongs to taxpayers. Development of the human papillomavirus (HPV) Gardasil and Cervarix vaccines is a case in point. The initial research was funded by the NIH, National Cancer Institute, University of Rochester, Georgetown University and the University of Queensland, which licensed them to Merck and GlaxoSmithKline. In 2015, Merck made $1.9 billion on its Gardasil franchise.

Dr. Brian Hooker Addresses Protest Crowd in N.Y. as Former CDC Director Who Approved Gardasil Vaccine is Named “Woman of the Year”

As we have previously reported here at Health Impact News, former CDC director, Dr. Julie Gerberding, has been referred to as either "one of the most evil people in medicine today" or the Healthcare Businesswomen's "Woman of the Year." A crowd gathered in New York City to protest the Healthcare Businesswomen's award, and Dr. Brian Hooker, who has spent many years of his life uncovering corruption at the CDC, addressed the crowd. He talked about the conversations he had with CDC whistleblower, Dr. Willliam Thompson, who worked with Dr. Gerberding during the years she served as the Director of the CDC, when the Gardasil vaccine was approved.

Study: Increased Rates of Cervical Cancer in Sweden Linked to Increase in HPV Vaccinations

A new study published in the Indian Journal of Medical Ethics examined cervical cancer rates among women in Sweden and discovered a link between increased cervical cancer rates among women aged 20-49 during a two-year period between 2014 and 2015, corresponding to increased HPV vaccination rates in this population group, years earlier, when mass HPV vaccinations started in Sweden. Women above the age of 50, during this two-year period, saw no significant cervical cancer increase, as they probably would not have been vaccinated with the HPV vaccine. Since the study casts doubt on the efficacy of the HPV vaccine, and, in fact, links the vaccine to increased cancer rates, it is highly unlikely you will read about this in the U.S. corporate-sponsored media, where nothing negative about the blockbuster HPV Gardasil vaccine is allowed.

Global Joint Statement from 5 Nations Meeting in Japan Exposes Injuries and Discrimination Against HPV Vaccine Victims

The dangers of the Gardasil HPV vaccine are routinely censored in the U.S., where the official medical and government position on the vaccine is that it is "safe and effective." Enjoying legal immunity in the U.S. for any harm suffered as a result of the Gardasil vaccine, Merck and the U.S. government are seeking to increase the market for the vaccine. News outside the U.S., however, is very different. Some governments, such as Japan, no longer recommend the vaccine, and there are lawsuits suing for damages resulting from the HPV vaccines in numerous countries. In March of 2018 an international symposium was held at the University of Tokyo and attended by representatives from the UK, Ireland, Japan, Colombia and Spain to discuss the needs of victims who have suffered, and in some cases died, as a result of the HPV vaccine. They discussed both the medical and legal needs of HPV vaccine victims. Representatives from these 5 nations, which include scientists and medical professionals, have issued a joint "Global Statement" regarding the victims of HPV vaccines that you are not likely to read in the U.S. corporate-sponsored "mainstream" media. In this "Global Statement," experts from these 5 nations are calling to "Suspend recommendation of HPV vaccines for routine immunization, until a safer system is established ensuring that serious side effects are avoided," and to "refrain from actions that discriminate against, or slander HPV vaccine victims." We republish the press release and Global Statement in full here at Health Impact News.

Merck Fighting Fraud Lawsuits in U.S. Courts on MMR and Gardasil Vaccines

Pharmaceutical giant, Merck, is facing charges of fraud in lawsuits filed in U.S. courts regarding their vaccine products. This is important information for the public to know, given the fact that the ever-growing vaccine market is expected to exceed $70 billion within the next few years, and that many states are trying to pass legislation to mandate vaccines without informed consent, all in the name of "the greater good" for public health. Federal government agencies tasked with protecting public health, along with the corporate "mainstream" media, which reportedly receives up to 70% of its advertising revenue from pharmaceutical companies, continue to censor any negative information regarding vaccines that could affect sales. And since one cannot sue a pharmaceutical company for damages or deaths due to vaccines in the United States, where they enjoy legal immunity, it is rare that a pharmaceutical company faces a day in court related to corruption or fraud for bad vaccine products. Therefore, one needs to turn to either the alternative media such as Health Impact News, or the foreign media outside the U.S., to learn about the dangers of vaccines, and the corruption behind many of them. There are currently two major federal lawsuits against Merck that are being litigated in U.S. courts: a whistleblower lawsuit from former Merck scientists claiming fraud regarding the MMR vaccine, which has been in the courts for eight years now, and a lawsuit against the Gardasil vaccine claiming fraud from a 16-year-old girl who allegedly suffered Postural Orthostatic Tachycardia Syndrome (POTS) after receiving the Gardasil vaccine.